VINC Stock Price, Vincerx, Inc. Quote, Chart

Market Summary

USD0.70-0.02

Delayed

-2.78%

VINC Alerts

GOLDMAN SACHS GROUP INC reported owning 3% of VINC [2024-04-09]

VINC Stock Price

View Fullscreen

VINC RSI Chart

VINC Valuation

Market Cap

20.7M

Price/Earnings (Trailing)

-0.54

EV/EBITDA

-0.39

Price/Free Cashflow

-0.59

MarketCap/EBT

-0.51

VINC Price/Sales (Trailing)

VINC Profitability

Return on Equity

6.1K%

Return on Assets

-345.08%

Free Cashflow Yield

-169.78%

VINC Fundamentals

VINC Revenue

VINC Earnings

Earnings (TTM)

-38.2M

Earnings Growth (Yr)

13.33%

Earnings Growth (Qtr)

-151.09%

Breaking Down VINC Revenue

Last 7 days

-12.5%

Last 30 days

-26.3%

Last 90 days

-61.3%

Trailing 12 Months

-56.2%

How does VINC drawdown profile look like?

VINC Financial Health

Current Ratio

0.72

VINC Investor Care

Shares Dilution (1Y)

39.01%

Diluted EPS (TTM)

-1.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2021	0	0	0	0
2020	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Vincerx, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Aug 11, 2023	seelenberger alexander a.	bought	9,967	0.9493	10,500	see remarks
Aug 10, 2023	izumi raquel e.	bought	3,199	0.93	3,440	see remarks
Aug 10, 2023	hamdy ahmed md	bought	5,167	0.9569	5,400	see remarks
Aug 10, 2023	thomas tom c	bought	4,750	0.95	5,000	see remarks
Aug 09, 2023	izumi raquel e.	bought	11,735	0.9002	13,036	see remarks
Aug 09, 2023	hamdy ahmed md	bought	15,994	0.9464	16,900	see remarks
Dec 14, 2022	izumi raquel e.	bought	25,427	0.8848	28,738	see remarks
Dec 14, 2022	hamdy ahmed md	bought	30,538	0.8656	35,280	chief executive officer
Dec 14, 2022	thomas tom c	bought	5,810	0.83	7,000	see remarks
Aug 25, 2022	lowe christopher p.	bought	19,138	1.6499	11,600	-

Which funds bought or sold VINC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	new	-	148,349	148,349	-%
May 16, 2024	Colony Group, LLC	new	-	10,000	10,000	-%
May 15, 2024	Point72 Asset Management, L.P.	added	176	4,424,530	4,831,420	0.01%
May 15, 2024	CITADEL ADVISORS LLC	reduced	-9.69	669,010	901,894	-%
May 15, 2024	GOLDMAN SACHS GROUP INC	reduced	-63.06	1,177,940	3,195,340	-%
May 15, 2024	KINGDON CAPITAL MANAGEMENT, L.L.C.	reduced	-50.00	1,039,500	1,948,100	0.21%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	reduced	-24.73	90,605	131,277	-%
May 15, 2024	MARSHALL WACE, LLP	new	-	362,124	362,124	-%
May 15, 2024	Sio Capital Management, LLC	unchanged	-	395,950	516,368	0.15%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-15.11	16,665	22,977	-%

Are Funds Buying or Selling VINC?

Are funds buying VINC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VINC

No. of Funds

VINC Alerts

GOLDMAN SACHS GROUP INC reported owning 3% of VINC [2024-04-09]

Unveiling Vincerx, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
May 03, 2024	prosight management, lp	9.1%	2,497,218	SC 13G
Apr 09, 2024	goldman sachs group inc	3.0%	631,490	SC 13G/A
Feb 14, 2024	long focus capital management, llc	5.1%	1,098,753	SC 13G/A
Feb 13, 2024	affinity asset advisors, llc	12.%	0	SC 13G/A
Feb 13, 2024	bank of america corp /de/	5.1%	1,082,863	SC 13G
Feb 05, 2024	goldman sachs group inc	8.0%	1,709,656	SC 13G/A
Feb 14, 2023	long focus capital management, llc	6.7%	1,414,951	SC 13G
Feb 13, 2023	affinity asset advisors, llc	7.04%	1,492,771	SC 13G/A
Feb 10, 2023	rubric capital management lp	1.83%	386,719	SC 13G/A
Feb 10, 2023	goldman sachs group inc	10.1%	2,147,849	SC 13G/A

Recent SEC filings of Vincerx, Inc.

View All Filings

Date Filed	Form Type	Document
May 14, 2024	10-Q	Quarterly Report
May 14, 2024	8-K	Current Report
May 03, 2024	SC 13G	Major Ownership Report
Apr 29, 2024	424B5	Prospectus Filed
Apr 26, 2024	8-K	Current Report
Apr 25, 2024	424B5	Prospectus Filed
Apr 25, 2024	8-K	Current Report
Apr 10, 2024	ARS	ARS
Apr 10, 2024	DEF 14A	DEF 14A
Apr 10, 2024	DEFA14A	DEFA14A

Peers (Alternatives to Vincerx, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	234.45%	75.34%	-4.58	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Vincerx, Inc. News

Latest updates

Vincerx, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In null)

Income Statement (Quarterly)
Description	(%) Q/Q	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q1
Revenue	-100.0%	-	15,359	3,349	-	-	-
Operating Expenses	3.1%	17,931	17,393	9,625	10,372	305	4.00
S&GA Expenses	-14.6%	5,720	6,695	4,791	3,256	305	4.00
EBITDA Margin	-187.8%	-0.01*	0.00*	-	-	-	-
Interest Expenses	-100.0%	-	25.00	-	-	-	-
Income Taxes	-	25.00	-	-	-	-	512*
Earnings Before Taxes	-	-	-	-	-	-	-10.95
EBT Margin	-131.6%	-0.01*	0.00*	-	-	-	-
Net Income	-1105.7%	-24,524	-2,034	-6,276	-16,276	-307	-4.00
Net Income Margin	-357.0%	-3.04*	-0.67*	-	-	-	-
Free Cashflow	-26.0%	-10,304	-8,175	-3,437	-2,135	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																		(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q2
Assets	-39.2%	11.00	18.00	26.00	35.00	47.00	59.00	72.00	88.00	104	118	129	91.00	58.00	63.00	66.00	66.00	67.00	-
Current Assets	-47.9%	8.00	15.00	23.00	32.00	44.00	56.00	67.00	82.00	98.00	112	123	87.00	54.00	63.00	1.00	1.00	1.00	0.00
Cash Equivalents	-59.4%	5.00	13.00	15.00	7.00	4.00	12.00	46.00	81.00	97.00	112	123	86.00	53.00	62.00	0.00	1.00	1.00	0.00
Net PPE	-11.2%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-
Liabilities	67.3%	12.00	7.00	11.00	11.00	13.00	12.00	13.00	13.00	15.00	17.00	29.00	20.00	32.00	38.00	4.00	3.00	3.00	-
Current Liabilities	89.7%	11.00	6.00	9.00	9.00	11.00	9.00	10.00	10.00	12.00	14.00	25.00	16.00	29.00	38.00	0.00	0.00	0.00	0.00
Shareholder's Equity	-105.5%	-0.62	11.00	16.00	24.00	34.00	48.00	60.00	74.00	89.00	100	101	72.00	26.00	25.00	5.00	5.00	5.00	0.00
Retained Earnings	-7.8%	-171	-159	-156	-146	-135	-118	-107	-90.82	-72.39	-55.97	-49.50	-24.97	-22.94	-16.66	-0.56	-0.12	-0.01	0.00
Additional Paid-In Capital	0.3%	171	170	172	171	170	167	167	165	162	156	150	97.00	57.00	42.00	6.00	5.00	5.00	0.00
Shares Outstanding	0.0%	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	18.00	15.00	14.00	-	-	-	-
Float	-	-	-	-	23.00	-	-	-	20.00	-	-	-	131	-	-	-	8.00	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q3
Cashflow From Operations	3.5%	-7,739	-8,019	-6,645	-12,697	-13,092	-13,817	-14,872	-15,887	-15,028	-11,486	-10,304	-8,175	-3,437	-2,135	-121	-	-	-
Share Based Compensation	-	-	-	-	-	-	-	2,290	3,362	5,258	-	6,075	6,637	4,715	-	-	-	-	-
Cashflow From Investing	-100.0%	-	5,750	15,061	14,804	5,885	-20,383	-20,195	-	-	-8.00	-22.00	-228	-5,000	-	-	-	-	-
Cashflow From Financing	-72.2%	5.00	18.00	-	93.00	3.00	38.00	-	242	-	283	47,499	-	-	63,891	-	-	66,438	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

VINC Income Statement

2024-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
General and administrative	$ 2,922	$ 4,497
Research and development	4,556	10,911
Total operating expenses	7,478	15,408
Loss from operations	(7,478)	(15,408)
Other income (expense)
Change in fair value of warrant liabilities	(5,204)	18
Interest income	99	466
Other income (expense)	154	274
Total other income (expense)	(4,951)	758
Net loss	(12,429)	(14,650)
Other comprehensive income:
Net foreign currency translation gain	52	30
Net unrealized gain on marketable securities	0	31
Comprehensive loss	$ (12,377)	$ (14,589)
Net loss per common share, basic	$ (0.58)	$ (0.69)
Net loss per common share, diluted	$ (0.58)	$ (0.69)
Weighted average common shares outstanding, basic	21,400	21,188
Weighted average common shares outstanding, diluted	21,400	21,188

VINC Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 5,110	$ 12,782
Restricted cash	82	72
Prepaid expenses	700	51
Grant receivable	1,025	1,044
Other current assets	760	784
Total current assets	7,677	14,733
Right-of-use assets, net	1,950	2,201
Property, plant and equipment, net	111	125
Grant receivable	1,207	1,076
Other assets	138	82
Total assets	11,083	18,217
Current liabilities
Accounts payable	2,314	2,497
Accrued expenses	1,727	1,755
Lease liability	1,198	1,162
Common stock warrant liabilities	5,395	191
Total current liabilities	10,634	5,605
Lease liability, net of current portion	1,021	1,340
Other noncurrent liabilities	50	50
Total liabilities	11,705	6,995
Stockholders' equity (deficit)
Preferred stock, $0.0001 par value; 30,000,000 shares authorized, none issued or outstanding as of March 31, 2024 and December 31, 2023	0	0
Common stock, $0.0001 par value; 120,000,000 shares authorized, 21,413,389 shares and 21,407,510 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	2	2
Additional paid-in capital	170,857	170,324
Accumulated other comprehensive income	60	8
Accumulated deficit	(171,541)	(159,112)
Total stockholders' equity (deficit)	(622)	11,222
Total liabilities and stockholders' equity (deficit)	$ 11,083	$ 18,217

About Vincerx, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

CEO	Dr. Ahmed M. Hamdy M.D.
WEBSITE	https://vincerx.com
INDUSTRY	Biotechnology
EMPLOYEES	41

Vincerx, Inc. Frequently Asked Questions

What is the ticker symbol for Vincerx, Inc.? What does VINC stand for in stocks?

VINC is the stock ticker symbol of Vincerx, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vincerx, Inc. (VINC)?

As of Fri May 17 2024, market cap of Vincerx, Inc. is 20.67 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VINC stock?

You can check VINC's fair value in chart for subscribers.

What is the fair value of VINC stock?

You can check VINC's fair value in chart for subscribers. The fair value of Vincerx, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Vincerx, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VINC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Vincerx, Inc. a good stock to buy?

The fair value guage provides a quick view whether VINC is over valued or under valued. Whether Vincerx, Inc. is cheap or expensive depends on the assumptions which impact Vincerx, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VINC.